🧠 What If Alzheimer’s Starts Inside Brain Cells — Before the Plaques Take Over?

For decades, Alzheimer’s disease has been strongly associated with amyloid beta plaques — sticky protein deposits that build up between neurons. This idea shaped an entire generation of drug development. But clearing plaques has not been enough to stop or reverse the disease, which suggests the real story may begin earlier and deeper inside the cell.

A new study from the University of California, Riverside, published in PNAS Nexus, proposes a different mechanism: amyloid beta may disrupt neurons by hijacking the same internal “tracks” normally used by tau, another key brain protein.

Inside neurons, microtubules act like tiny railways, helping move vital cargo through long and fragile nerve-cell branches. Tau normally stabilizes these tracks. But the researchers found that amyloid beta can bind to microtubules with roughly similar strength — meaning that, if it accumulates inside neurons, it may compete with tau and push it away from its normal job.

That could trigger a dangerous cascade: microtubules become unstable, cellular transport starts to fail, and displaced tau begins to misbehave — clumping, becoming chemically modified, and moving into parts of the neuron where it does not belong.

In this model, plaques outside cells may not be the original weapon. They may be a visible downstream sign of a much earlier intracellular failure.

Why this matters:

🔹 Amyloid beta and tau appear to compete for overlapping binding sites on microtubules
🔹 The damage may begin inside neurons, before external plaques dominate the picture
🔹 Aging-related decline in autophagy — the cell’s recycling system — could allow amyloid beta to build up internally
🔹 The model may help explain why plaque-clearing drugs have shown limited clinical impact
🔹 It points toward new strategies: protecting microtubules, supporting tau function, or improving intracellular protein cleanup

Important caveat: this is not a clinical trial and not proof that this mechanism causes Alzheimer’s in humans. It is a proposed model based on laboratory experiments — but an interesting one, because it connects two major Alzheimer’s hallmarks, amyloid beta and tau, through the same cellular structure.

More than 57 million people worldwide live with dementia, and Alzheimer’s disease accounts for the majority of cases. If this microtubule-competition model holds up, it could shift part of the field from simply removing plaques to protecting the neuron’s internal transport system before it breaks.

Maybe the real crime scene was never just between brain cells.

Maybe it was inside them all along.

Source: https://doi.org/10.1093/pnasnexus/pgag034

#Alzheimers #Neuroscience #BrainHealth #Dementia #PNASNexus #science